Literature DB >> 23287860

Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy.

Yoshinori Takahashi1, Tsukasa Hori, Timothy K Cooper, Jason Liao, Neelam Desai, Jacob M Serfass, Megan M Young, Sungman Park, Yayoi Izu, Hong-Gang Wang.   

Abstract

Malignant transformation by oncogenes requires additional genetic/epigenetic changes to overcome enhanced susceptibility to apoptosis. In the present study, we report that Bif-1 (Sh3glb1), a gene encoding a membrane curvature–driving endophilin protein, is a haploinsufficient tumor suppressor that plays a key role in the prevention of chromosomal instability and suppresses the acquisition of apoptosis resistance during Myc-driven lymphomagenesis. Although a large portion of Bif-1–deficient mice harboring an Eμ-Myc transgene displayed embryonic lethality, allelic loss of Bif-1 dramatically accelerated the onset of Myc-induced lymphoma. At the premalignant stage, hemizygous deletion of Bif-1 resulted in an increase in mitochondrial mass, accumulation of DNA damage, and up-regulation of the antiapoptotic protein Mcl-1. Consistently, allelic loss of Bif-1 suppressed the activation of caspase-3 in Myc-induced lymphoma cells. Moreover, we found that Bif-1 is indispensable for the autophagy-dependent clearance of damaged mitochondria (mitophagy), because loss of Bif-1 resulted in the accumulation of endoplasmic reticulum–associated immature autophagosomes and suppressed the maturation of autophagosomes. The results of the present study indicate that Bif-1 haploinsufficiency attenuates mitophagy and results in the promotion of chromosomal instability, which enables tumor cells to efficiently bypass the oncogenic/metabolic pressures for apoptosis. .

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23287860      PMCID: PMC3587325          DOI: 10.1182/blood-2012-10-459826

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Bif-1 regulates Atg9 trafficking by mediating the fission of Golgi membranes during autophagy.

Authors:  Yoshinori Takahashi; Cheryl L Meyerkord; Tsukasa Hori; Kristin Runkle; Todd E Fox; Mark Kester; Thomas P Loughran; Hong-Gang Wang
Journal:  Autophagy       Date:  2011-01-01       Impact factor: 16.016

Review 2.  Mechanisms of mitophagy.

Authors:  Richard J Youle; Derek P Narendra
Journal:  Nat Rev Mol Cell Biol       Date:  2011-01       Impact factor: 94.444

3.  3D tomography reveals connections between the phagophore and endoplasmic reticulum.

Authors:  Päivi Ylä-Anttila; Helena Vihinen; Eija Jokitalo; Eeva-Liisa Eskelinen
Journal:  Autophagy       Date:  2009-11-08       Impact factor: 16.016

4.  Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis.

Authors:  Jessie Yanxiang Guo; Hsin-Yi Chen; Robin Mathew; Jing Fan; Anne M Strohecker; Gizem Karsli-Uzunbas; Jurre J Kamphorst; Guanghua Chen; Johanna M S Lemons; Vassiliki Karantza; Hilary A Coller; Robert S Dipaola; Celine Gelinas; Joshua D Rabinowitz; Eileen White
Journal:  Genes Dev       Date:  2011-02-11       Impact factor: 11.361

5.  Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.

Authors:  Kirsteen J Campbell; Mary L Bath; Marian L Turner; Cassandra J Vandenberg; Philippe Bouillet; Donald Metcalf; Clare L Scott; Suzanne Cory
Journal:  Blood       Date:  2010-07-14       Impact factor: 22.113

Review 6.  The double-edged sword of autophagy modulation in cancer.

Authors:  Eileen White; Robert S DiPaola
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

Review 7.  Bif-1/endophilin B1: a candidate for crescent driving force in autophagy.

Authors:  Y Takahashi; C L Meyerkord; H-G Wang
Journal:  Cell Death Differ       Date:  2009-03-06       Impact factor: 15.828

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin.

Authors:  Atsushi Tanaka; Megan M Cleland; Shan Xu; Derek P Narendra; Der-Fen Suen; Mariusz Karbowski; Richard J Youle
Journal:  J Cell Biol       Date:  2010-12-20       Impact factor: 10.539

10.  The landscape of somatic copy-number alteration across human cancers.

Authors:  Rameen Beroukhim; Craig H Mermel; Dale Porter; Guo Wei; Soumya Raychaudhuri; Jerry Donovan; Jordi Barretina; Jesse S Boehm; Jennifer Dobson; Mitsuyoshi Urashima; Kevin T Mc Henry; Reid M Pinchback; Azra H Ligon; Yoon-Jae Cho; Leila Haery; Heidi Greulich; Michael Reich; Wendy Winckler; Michael S Lawrence; Barbara A Weir; Kumiko E Tanaka; Derek Y Chiang; Adam J Bass; Alice Loo; Carter Hoffman; John Prensner; Ted Liefeld; Qing Gao; Derek Yecies; Sabina Signoretti; Elizabeth Maher; Frederic J Kaye; Hidefumi Sasaki; Joel E Tepper; Jonathan A Fletcher; Josep Tabernero; José Baselga; Ming-Sound Tsao; Francesca Demichelis; Mark A Rubin; Pasi A Janne; Mark J Daly; Carmelo Nucera; Ross L Levine; Benjamin L Ebert; Stacey Gabriel; Anil K Rustgi; Cristina R Antonescu; Marc Ladanyi; Anthony Letai; Levi A Garraway; Massimo Loda; David G Beer; Lawrence D True; Aikou Okamoto; Scott L Pomeroy; Samuel Singer; Todd R Golub; Eric S Lander; Gad Getz; William R Sellers; Matthew Meyerson
Journal:  Nature       Date:  2010-02-18       Impact factor: 49.962

View more
  37 in total

Review 1.  Therapeutic targeting of autophagy in disease: biology and pharmacology.

Authors:  Yan Cheng; Xingcong Ren; William N Hait; Jin-Ming Yang
Journal:  Pharmacol Rev       Date:  2013-08-13       Impact factor: 25.468

Review 2.  Mending a broken heart: the role of mitophagy in cardioprotection.

Authors:  Alexandra G Moyzis; Junichi Sadoshima; Åsa B Gustafsson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-11-26       Impact factor: 4.733

Review 3.  Mitophagy in tumorigenesis and metastasis.

Authors:  Logan P Poole; Kay F Macleod
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

4.  Atg2A/B deficiency switches cytoprotective autophagy to non-canonical caspase-8 activation and apoptosis.

Authors:  Zhenyuan Tang; Yoshinori Takahashi; Chong Chen; Ying Liu; Haiyan He; Nikolaos Tsotakos; Jacob M Serfass; Melat T Gebru; Han Chen; Megan M Young; Hong-Gang Wang
Journal:  Cell Death Differ       Date:  2017-08-11       Impact factor: 15.828

5.  Bif-1 Interacts with Prohibitin-2 to Regulate Mitochondrial Inner Membrane during Cell Stress and Apoptosis.

Authors:  Sung-Gyu Cho; Xiao Xiao; Shixuan Wang; Hua Gao; Ruslan Rafikov; Stephen Black; Shang Huang; Han-Fei Ding; Yisang Yoon; Robert A Kirken; Xiao-Ming Yin; Hong-Gang Wang; Zheng Dong
Journal:  J Am Soc Nephrol       Date:  2019-05-24       Impact factor: 10.121

Review 6.  DAMPs, ageing, and cancer: The 'DAMP Hypothesis'.

Authors:  Jin Huang; Yangchun Xie; Xiaofang Sun; Herbert J Zeh; Rui Kang; Michael T Lotze; Daolin Tang
Journal:  Ageing Res Rev       Date:  2014-10-30       Impact factor: 10.895

7.  Bax interacting factor-1 promotes survival and mitochondrial elongation in neurons.

Authors:  David B Wang; Takuma Uo; Chizuru Kinoshita; Bryce L Sopher; Rona J Lee; Sean P Murphy; Yoshito Kinoshita; Gwenn A Garden; Hong-Gang Wang; Richard S Morrison
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

Review 8.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 9.  Molecular pathways: autophagy in cancer--a matter of timing and context.

Authors:  Michelle Cicchini; Vassiliki Karantza; Bing Xia
Journal:  Clin Cancer Res       Date:  2014-08-27       Impact factor: 12.531

Review 10.  HMGB1 in cancer: good, bad, or both?

Authors:  Rui Kang; Qiuhong Zhang; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Clin Cancer Res       Date:  2013-05-30       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.